Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Genomic Instability × Vemurafenib × Thoracic × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 4 Thyroid Carcinoma, Anaplastic 1 Thyroid Cancer, Papillary 1 Ovarian Neoplasms 1 Neoplasms by Site 1 Neoplasms by Histologic Type 1 Neoplasms 1 Multiple Myeloma 1 Melanoma 1 Laryngeal Neoplasms 1 Hematologic Neoplasms 1 Glioma 1 Genomic Instability 1 Gastrointestinal Neoplasms 1 Erdheim-Chester Disease 1 Colorectal Neoplasms 1 Breast Neoplasms 1

Interventions

atezolizumab 1 alectinib 1 Vemurafenib 1 Ado-Trastuzumab Emtansine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02314481 2025-05-23

DARWINII

University College, London

Phase 2 Active not recruiting

Carcinoma, Non-Small-Cell Lung, Genomic Instability

Data powered by HemOnc (CC BY 4.0) Colophon ⚡